What This Bill Does · Plain English
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Frequently Asked Questions
Did HR.6423 pass?
HR.6423 is still alive. Current stage: COMMITTEE. Pass likelihood: pending.
Who sponsored HR.6423?
HR.6423 was sponsored by Thomas H. Kean (R-New Jersey).
Full Bill Text
119 HR 6423 IH: Help Ensure Lower Patient Copays Act U.S. House of Representatives 2025-12-04 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 6423 IN THE HOUSE OF REPRESENTATIVES December 4, 2025 Mr. Kean (for himself, Ms. Barragán , Mrs. Miller-Meeks , Mr. Auchincloss , Mr. Fitzpatrick , and Mrs. Watson Coleman ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XXVII of the Public Health Service Act to apply financial assistance towards the cost-sharing requirements of health insurance plans, and for other purposes. 1. Short title This Act may be cited as the Help Ensure Lower Patient Copays Act or the HELP Copays Act . 2. Application of financial assistance toward cost-sharing requirements (a) Application toward cost-Sharing requirements Section 2715(g)(1) of the Public Health Service Act ( 42 U.S.C. 300gg–15(g)(1) ) is amended by adding at the end the following: In developing the standards for defining the terms deductible , coinsurance , copayment , and out-of-pocket limit (as described in paragraph (2)), such standards shall provide that such terms include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and that such amounts shall be counted toward such deductible, coinsurance, copayment, or limit, respectively. . (b) Conforming amendments (1) PPACA Section 1302(c)(3) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(c)(3) ) is amended by adding at the end the following new subparagraph: (C) Application of terms For purposes of subparagraph (A), the terms deductible , coinsurance , copayment , or similar charge and any other expenditure described in clause (ii) of such subparagraph shall include amounts paid by, or on behalf of, an individual enrolled in a group health plan or group or individual health insurance coverage, including financial assistance offered by non-profit organizations and prescription drug manufacturers, and such amounts shall be counted toward such deductible, co-insurance, co-payment, charge, or other expenditure, respectively. . (2) PHSA Section 2707(b) of the Public Health Service Act ( 42 U.S.C. 300gg–6(b) ) is amended by adding at the end the following new sentence: For purposes of the previous sentence, such limitation shall be applied to prescription drugs as if the reference to essential health benefits in section 1302(c)(3) of the Patient Protection and Affordable Care Act were a reference to any item or service covered under the plan included within the prescription drug category of essential health benefits as described in (b)(1)(F) of such section . . (3) Internal Revenue Code of 1986 safe harbor for certain amounts applied to deductibles Section 223(c)(2) of the Internal Revenue Code of 1986 is amended by adding at the end the following new subparagraph: (H) Safe harbor for certain amounts applied to deductibles In the case of plan years beginning after December 31, 2025, a plan shall not fail to be treated as a high deductible health plan by reason of counting amounts paid by, or on behalf of, an individual, including financial assistance offered by non-profit organizations and prescription drug manufacturers for outpatient prescription drugs, when determining whether the minimum deductible under subparagraph (A) has been satisfied. . (c) Rule of construction The amendments made by this section shall— (1) apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to prescription drugs that are specialty drugs; (2) apply to standards relating to deductibles, coinsurance, copayments, or limits with respect to drugs that are subject to utilization management; and (3) not impact the use of utilization management tools, including prior authorization and step therapy. (d) Effective date This section, and the amendments made by this section, shall apply to group health plans and health insurance issuers for plan years beginning on or after January 1, 2026.
Loading intelligence layer…